The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 0094/5016R.
Iglu Sugar Free Pastilles
iglü® sugar free pastilles
Benzalkonium Chloride Solution 1.11 mg and Compound Benzoin Tincture 8.06 mg
Keep this leaflet. You may need to read it again. Ask your doctor, dentist or pharmacist if you need more information or advice. You must contact a doctor or dentist if your symptoms worsen or do not improve after 7 days. If any of the side effects get serious, or if you notice any side effect not listed in this leaflet (see section 4), please tell your doctor, dentist or pharmacist.
1. What Iglü Sugar Free Pastilles are and what they are used for
2. Before you take Iglü Sugar Free Pastilles
3. How to take Iglü Sugar Free Pastilles
4. Possible side effects
5. How to store Iglü Sugar Free Pastilles
6. Further information
Do not take Iglü Sugar Free Pastilles if you are allergic (hypersensitive) to benzalkonium chloride solution, compound benzoin tincture or any of the other ingredients in this medicine as listed in Section 6.
Do not give to children under 3 years.
If you are pregnant or breast-feeding, talk to your doctor or pharmacist before using this medicine.
Using this product is not known to affect your ability to drive or use machinery.
Always take Iglü Sugar Free Pastilles by mouth.
overdosage of the active ingredient is unlikely to occur because of the low concentrations used and the small pack size. If the dosage is grossly exceeded, sickness/nausea and vomiting may occur. If this happens you should seek medical advice.
If you occasionally forget to take Iglü Sugar Free Pastilles do not worry, just carry on using them when you remember.
If you have any further questions on the use of this medicine, ask your doctor, dentist or pharmacist.
Like all medicines, Iglü Sugar Free Pastilles can cause side effects, although not everyone gets them.
On rare occasions, hypersensitivity reactions to benzalkonium chloride occur involving difficulty in breathing, swelling of the face, neck, tongue or throat and a rash (severe allergic reactions). Stop taking this medicine and seek urgent medical attention if you experience these symptoms.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Each pastille contains the active ingredients benzalkonium chloride solution 1.11 mg and compound benzoin tincture 8.06 mg.
The other ingredients are sorbitol liquid (non crystallising), acacia, peppermint oil, simethicone antifoam, vegetable oil, carnauba wax, water.
This leaflet was last revised in
Other formats – To request a copy of this leaflet in Braille, large print or audio please call 01363 636000.